PharmaSGP Holding SE Cash Flow Quality Index
PharmaSGP Holding SE cash flow quality index. PharmaSGP Holding SE (PSG) has a Cash Flow Quality Index of 0.89x as of March 2025. Operating cash flow of €4.22 Million is below net income of €4.73 Million, suggesting accrual-heavy earnings not yet converted to cash. See PSG financial flexibility index to measure the company's free cash flow as a share of total liabilities.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Cash Flow Quality Index of PharmaSGP Holding SE (2014–2024)
Cash flow quality index of PharmaSGP Holding SE from 2014 to 2024. Historical Cash Flow Quality Index for PharmaSGP Holding SE across 11 annual periods. Values consistently above 1.0x indicate high-quality earnings. Explore PSG operating cash to total liabilities to assess how comfortably operating cash covers total debt obligations.
PharmaSGP Holding SE Cash Flow Quality Index by Year (2014–2024)
PharmaSGP Holding SE cash flow quality index by year from 2014 to 2024. Year-by-year earnings quality comparison for PharmaSGP Holding SE. For the full cash flow conversion analysis, see PharmaSGP Holding SE (PSG) cash conversion ratio.
| Year | Quality Index | Operating CF (EUR) | Net Income | YoY Change |
|---|---|---|---|---|
| 2024 | 1.27x | €24.88 Million | €19.54 Million | ▼ -21.6% |
| 2023 | 1.62x | €26.64 Million | €16.40 Million | ▼ -21.4% |
| 2022 | 2.07x | €24.71 Million | €11.95 Million | ▲ +80.6% |
| 2021 | 1.14x | €12.24 Million | €10.69 Million | ▼ -21.2% |
| 2020 | 1.45x | €15.46 Million | €10.64 Million | ▲ +37.7% |
| 2019 | 1.06x | €17.63 Million | €16.71 Million | ▲ +84.5% |
| 2018 | 0.57x | €8.43 Million | €14.73 Million | ▼ -52.7% |
| 2017 | 1.21x | €14.25 Million | €11.78 Million | ▲ +76.7% |
| 2016 | 0.68x | €3.55 Million | €5.18 Million | ▼ -55.2% |
| 2015 | 1.53x | €10.59 Million | €6.93 Million | ▼ -24.4% |
| 2014 | 2.02x | €5.41 Million | €2.68 Million | — |